India complains to Beijing over treatment of diplomat
NEW DELHI (Reuters) - China has agreed to look into a complaint by India's foreign ministry that a diplomat was prevented from treating his severe diabetes and collapsed while offering consular assistance to two Indian citizens on trial in China's Yiwu city.
S. Balachandran from the Indian consulate in Shanghai, had to be hospitalised after attending a court hearing that lasted five hours without being able to treat his condition, said an Indian government source who declined to be named.
"We have taken it up pretty strongly with the Chinese, that this is no way to treat a diplomat, that he should be allowed access to medication," the source said. But the source denied Indian media reports that the diplomat had been attacked by an angry crowd for defending the two businessmen on trial.
A Chinese diplomat in New Delhi said the incident would be investigated.
"I believe both governments ... will handle this properly, this seems to be a civil-civic commercial dispute," China's charge d'affaires Zhang Yue said after meeting with officials at India's foreign ministry.
"We are trying to figure out what happened," he said.
Yiwu is a small city known for manufacturing and a commodities wholesale market that attracts traders from across Asia.
Although annual bilateral trade between India and China is more than $50 billion, the neighbours have a tense diplomatic relationship linked to a brief but bloody border war in 1962 over national boundaries which remain unsettled.
(Additional reporting by Sunil Kataria; Editing by Ed Lane)
- Tweet this
- Share this
- Digg this
- Israel extends Gaza ceasefire for 24 hours, Hamas rejects terms
- Australia approves Adani's $16 bln Carmichael coal project
- U.S. diplomats' return to Libya could be more hazardous than exit
- Analysis - Amazon's far-reaching ambitions, lack of profits, unnerve investors
- Reliance Power to buy Jaiprakash's hydropower business
The Indian subsidiary of Anglo-Dutch parent Unilever made a net profit of 10.57 billion rupees ($175.9 million) for the three months ended June 30, from 10.19 billion rupees in the same period a year earlier. Full Article